Ctx3 Rinse

Description

CTx3R is available in three distinct flavors: Mint, Citrus, and Grape. Each formulation is designed to provide a unique sensory experience while maintaining the same active ingredients and therapeutic efficacy. The product is enclosed in labels that clearly indicate the flavor variant, ensuring proper identification and usage.

Uses and Indications

This drug is indicated for the prevention of dental caries (cavities). It is intended for use in individuals at risk of developing dental caries, including children and adults. Regular use as part of a comprehensive oral hygiene regimen is recommended to maximize its effectiveness in reducing the incidence of cavities.

Dosage and Administration

Adults and children 6 years of age and older should use the rinse once daily, following brushing with toothpaste. The recommended method involves vigorously swishing 10 mL of the rinse between the teeth for one minute, after which the solution should be spat out. It is imperative that the rinse is not swallowed. Additionally, patients should refrain from eating or drinking for 30 minutes following the rinsing procedure.

For children under 12 years of age, it is essential to instruct them in proper rinsing techniques to minimize the risk of swallowing the rinse. Supervision may be required until the child is capable of using the rinse independently.

For children under 6 years of age, consultation with a dentist or physician is advised prior to use.

Contraindications

Use is contraindicated in individuals who are unable to keep the product out of reach of children. This precaution is necessary to prevent accidental ingestion or misuse by pediatric patients. No other contraindications have been identified.

Warnings and Precautions

It is imperative to keep this product out of reach of children to prevent accidental ingestion. In the event that more than the recommended amount used for rinsing is accidentally swallowed, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Healthcare professionals should advise patients to discontinue use and seek dental consultation if they experience any unusual symptoms during the course of treatment. Monitoring for adverse reactions is essential to ensure patient safety and effective management of any potential side effects.

Side Effects

Patients should be aware of the following warnings associated with the use of this product. It is imperative to keep the product out of reach of children to prevent accidental ingestion. In the event that more than the recommended amount used for rinsing is swallowed, patients are advised to seek medical assistance or contact a Poison Control Center immediately.

Additionally, if patients experience any unusual symptoms while using the product, they should discontinue use and promptly contact their dentist for further evaluation and guidance. These precautions are essential to ensure the safety and well-being of individuals using the product.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Ctx3 Rinse (anticaries). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be instructed to keep the product out of reach of children. In the event that more than the recommended amount for rinsing is accidentally swallowed, immediate medical assistance or contact with a Poison Control Center is advised.

For children aged 6 years and older, the recommended usage is once daily after brushing teeth with toothpaste. Patients should vigorously swish 10 mL of the rinse between their teeth for one minute and then spit it out. It is important that the rinse is not swallowed, and patients should refrain from eating or drinking for 30 minutes following rinsing.

Children under 12 years of age should be guided in proper rinsing techniques to minimize the risk of swallowing the rinse. Supervision is recommended until the child is capable of using the product without assistance. For children under 6 years of age, consultation with a dentist or physician is necessary prior to use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients.

It is advisable to monitor elderly patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population. Consideration of individual patient factors, including comorbidities and concurrent medications, is essential in managing treatment effectively in this demographic.

Pregnancy

There is no specific information regarding the use of CTX3 Rinse during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this product to pregnant patients. Given the absence of established risk categories or known fetal impacts, it is advisable to weigh the potential benefits against any unknown risks when treating women of childbearing potential.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If an individual accidentally swallows more than the amount intended for rinsing, it is imperative to seek medical help or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt intervention can significantly mitigate potential adverse effects associated with overdosage. Monitoring for symptoms and providing appropriate management based on clinical presentation is essential.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage and handling to ensure the safety of young individuals.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It is essential to store the product at temperatures below 30 degrees Celsius (86 degrees Fahrenheit) to maintain its efficacy. Freezing the product is strictly prohibited, as it may compromise its integrity. Proper storage conditions must be adhered to in order to ensure optimal performance and safety.

Additional Clinical Information

Patients aged 6 years and older should use the rinse once daily after brushing their teeth with toothpaste. They should vigorously swish 10 mL of the rinse between their teeth for one minute before spitting it out, ensuring not to swallow the rinse. It is advised not to eat or drink for 30 minutes following the rinsing. Clinicians should instruct children under 12 years in proper rinsing techniques to minimize swallowing and supervise them as necessary. For children under 6 years of age, consultation with a dentist or physician is recommended.

Clinicians should counsel patients to keep the product out of reach of children. In the event that more than the recommended amount is accidentally swallowed, medical assistance or contact with a Poison Control Center should be sought immediately. Patients are advised to discontinue use and consult their dentist if they experience any unusual symptoms.

Drug Information (PDF)

This file contains official product information for Ctx3 Rinse, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)